Home › Funds › CM Management, LLC › RIGL

CM Management, LLC position in RIGL

RIGEL PHARMACEUTICALS INC · Health Care

CM Management, LLC reported holding 250,000 shares of RIGL (RIGEL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 8.08% of its reported portfolio and ranking #1 among its reported holdings. CM Management, LLC has disclosed RIGL holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)250.00K sh
Reported value held$12.04M
Portfolio Weight8.08%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CM Management, LLC's RIGL position evolved

CM Management, LLC first disclosed a stake in RIGL in Q3 2023 at 1,500,000 shares (US$1.6M). The position peaked in Q3 2026 at 250,000 shares, worth US$12.0M. Across 12 filings, CM Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 250,000 shares valued at US$12.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.50M $1.62M New
Q4 2023 1.70M $2.46M Add
Q1 2024 2.00M $2.96M Add
Q3 2024 290.00K $4.69M New
Q4 2024 242.50K $4.08M Reduce
Q1 2025 250.00K $4.50M Add
Q2 2025 250.00K $4.68M Hold
Q3 2025 225.00K $6.37M Reduce
Q4 2025 225.00K $9.64M Hold
Q1 2026 235.00K $6.35M Add
Q2 2026 250.00K $9.78M Add
Q3 2026 250.00K $12.04M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RIGL and 13F data

RIGL (RIGEL PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in RIGL — the largest reported positions include Soleus Capital Management, L.P. (US$72.1M), ARMISTICE CAPITAL, LLC (US$65.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RIGL

All RIGL fund holders →

FAQ

How long has CM Management, LLC held RIGL?

CM Management, LLC has disclosed RIGL holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is CM Management, LLC's current position in RIGL?

As of Q3 2026, CM Management, LLC holds 250.00K shares of RIGL (RIGEL PHARMACEUTICALS INC), valued at $12.04M, representing 8.08% of its reported portfolio and ranking #1.

Has CM Management, LLC been buying or selling RIGL?

In the latest 13F filing (Q3 2026), CM Management, LLC held unchanged its position in RIGL. The position peaked in Q3 2026 at 250.00K shares.

Which other funds hold RIGL?

Other major institutional holders of RIGL include Soleus Capital Management, L.P., ARMISTICE CAPITAL, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.